Karin Muraoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karin Muraoka has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Akio Kishida
Laboratory for Biomaterials and Bioengineering, Institute of Integrated Research, Institute of Science Tokyo, Tokyo 101-0062, Japan
1 shared publication - Anri Koyanagi
Department of Pathology, Institute of Science Tokyo Hospital, 1-5-45 Yushima, Bunkyoku, Tokyo 113-8510, Japan
1 shared publication - Iichiroh Onishi
Department of Pathology, Institute of Science Tokyo , Tokyo
1 shared publication - Masanobu Kitagawa
Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8519, Japan
1 shared publication - Morito Kurata
Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
1 shared publication - Tsuyoshi Kimura
Department of Biomedical Engineering, Faculty of Life Science, Toyo University, 48-1 Oka, Asaka-shi 351-8510, Saitama, Japan
1 shared publication
Latest Publications
- Open Access
- 26 November 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (12) , 1299
SRRM4 Knockout Helps the Human Mesenchymal Stem Cell Line to Penetrate Decellularized Cancellous Bone
Background: Analyzing the human bone marrow microenvironment requires an in vivo model that reflects the human bone marrow microenvironment. Introducing a human bone marrow mesenchymal stem cell (MSC) line into decellularized cancellous bone (DCB) is a first step in forming such a bone marrow model. Our goal with this research is identifying factors that promote the penetration of MSCs into DCBs in an ex vivo setting. Methods: We introduced the CRISPR Knock Out (GeCKO v2) library to identify candidate genes in UE7T-9 cell line (MSC line) for DCB penetration. We established a candidate gene-knockout UE7T-9 cell for validation and evaluated its penetration into DCB (measured distance of randomly selected 100 cells), proliferation (MTS assay), migration (scratch assay), and ancorage-independent growth (soft agar assay). RNA sequencing was performed to analyze changes in gene expression comprehensively. Results: We identified Serine/Arginine Repetitive Matrix 4 (SRRM4) knockout (KO) in the UE7T-9 cell as a candidate factor for bone penetration. SRRM4 KO promoted DCB penetration (3.1–7.1 times deeper, each p ≤ 1.91 × 10−24), cell migration (p = 0.039), and ancorage-independent growth (2.5 times in colony count, 7.1 times in colony size, each p = 0.001) but retained stem cell characteristics. Conclusions: SRRM4 KO is a newly defined factor of UE7T-9 cell penetrating into DCB. SRRM4 KO UE7T-9 cells may be used to analyze hematological diseases such as myelodysplastic neoplasms.
- 26 November 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (12) , 1299
Open AccessSRRM4 Knockout Helps the Human Mesenchymal Stem Cell Line to Penetrate Decellularized Cancellous Bone
Background: Analyzing the human bone marrow microenvironment requires an in vivo model that reflects the human bone marrow microenvironment. Introducing a human bone marrow mesenchymal stem cell (MSC) line into decellularized cancellous bone (DCB) is a first step in forming such a bone marrow model. Our goal with this research is identifying factors that promote the penetration of MSCs into DCBs in an ex vivo setting. Methods: We introduced the CRISPR Knock Out (GeCKO v2) library to identify candidate genes in UE7T-9 cell line (MSC line) for DCB penetration. We established a candidate gene-knockout UE7T-9 cell for validation and evaluated its penetration into DCB (measured distance of randomly selected 100 cells), proliferation (MTS assay), migration (scratch assay), and ancorage-independent growth (soft agar assay). RNA sequencing was performed to analyze changes in gene expression comprehensively. Results: We identified Serine/Arginine Repetitive Matrix 4 (SRRM4) knockout (KO) in the UE7T-9 cell as a candidate factor for bone penetration. SRRM4 KO promoted DCB penetration (3.1–7.1 times deeper, each p ≤ 1.91 × 10−24), cell migration (p = 0.039), and ancorage-independent growth (2.5 times in colony count, 7.1 times in colony size, each p = 0.001) but retained stem cell characteristics. Conclusions: SRRM4 KO is a newly defined factor of UE7T-9 cell penetrating into DCB. SRRM4 KO UE7T-9 cells may be used to analyze hematological diseases such as myelodysplastic neoplasms.